About Us

  • 2023Year

    Listed on the Shenzhen Stock Exchange GEM, opening a new chapter of innovation and development! Stock abbreviation: Hongyuan Pharmaceutical, stock code: 301246.

  • 2022Year

    Revenue exceeded 2 billion yuan.

  • 2019Year

    The first tax payment of more than 100 million yuan.

  • 2014Year

    Listed in the national small and medium-sized enterprise share transfer system, stock code: 831265.

  • 2010Year

    Development of "the use of fluid phase reaction method to produce lithium hexafluorophosphate technology", into new energy.

  • 2006Year

    For the first time to obtain drug approval number (metronidazole), and in the same year for the first time through GMP certification.